IONS vs MKTX · rev $226.6M vs P/E 13, rev $817.1M
Ionis Pharmaceuticals Inc (IONS) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
IONS currently screens at market cap $12.28B. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the IONS and MKTX stock pages for the full models.
Not investment advice.